Rolling Oaks Radiology, a division of RadNet, has installed GE Healthcare's SenoBright contrast-enhanced spectral mammography (CESM) at its Oxnard, Calif. location.
CESM uses an injectable contrast agent to analyze blood flow patterns within breast tissue. This provides a contrast-enhanced image of suspicious masses and can be used to complement the conventional mammogram image. The CESM technique removes normal tissue signals and identifies potentially abnormal tissue, which enhances with the contrast.
Clinical indications for CESM include: When a screening mammogram or ultrasound are inconclusive, in high-risk patients with dense breasts, for preoperative planning in known breast cancer, a suspicious palpable finding with negative mammogram or ultrasound and when a patient is unable to have a MRI.
To read more about the roles of adjunctive breast imaging modalities, click "Move Over Mammo," in the July/August issue of Health Imaging.